Anti-TFPI Recombinant Antibody (Concizumab) (CAT#: TAB-734)

Recombinant humanized antibody expressed in CHO binding to human TFPI. Concizumab is a monoclonal IgG4 antibody (mAb) that binds to the Kunitz-type protease inhibitor (KPI) 2 domain of TFPI thereby blocking the interaction of this domain with the active site of FXa.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
PK

Figure 1 PK result of the antibody.

Figure 1 PK result of the antibody.

Mean PK profiles of concizumab concentration (log scale) up to 43 days after i.v. and s.c. administration of concizumab or placebo to healthy volunteers and hemophilia patients.

Chowdary, P., Lethagen, S., Friedrich, U., Brand, B., Hay, C., Abdul Karim, F.,... & Miesbach, W. (2015). Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. Journal of Thrombosis and Haemostasis, 13(5), 743-754.

ELISA

Figure 2 ELISA result of the antibody.

Figure 2 ELISA result of the antibody.

Mean free TFPI plasma concentration (ng mL−1) evaluated by TFPI ELISA up to 43 days after i.v. and s.c. administration of concizumab or placebo to healthy volunteers and hemophilia patients.

Chowdary, P., Lethagen, S., Friedrich, U., Brand, B., Hay, C., Abdul Karim, F.,... & Miesbach, W. (2015). Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. Journal of Thrombosis and Haemostasis, 13(5), 743-754.


Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • undefined
  • Derivation
  • Humanized
  • Type
  • IgG4 - kappa
  • Species Reactivity
  • Human
  • Applications
  • ELISA, IP, FC, FuncS, Neut, IF, WB, PK
  • Generic Name
  • concizumab
  • Related Disease
  • Hemophilia

Product Property

  • Purity
  • >95.0% as determined by Analysis by RP-HPLC & analysis by SDS-PAGE.
  • Storage
  • Store at -20°C. Avoid multiple freeze/thaw cycles.

Applications

  • Application Notes
  • The TFPI antibody has been reported in applications of ELISA, IP, FC, FuncS, Neut, IF, WB, PK.

Target

  • Alternative Names
  • concizumab;mAb 2021;4F110 ;TFPI;tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor);LACI;tissue factor pathway inhibitor;EPI;extrinsic pathway inhibitor;TFI;TFPI1;anti-convertin;

Related Resources

  • Biosimilar Overview
Please refer to Concizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Concizumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Concizumab"

Afuco™ Anti-TFPI ADCC Recombinant Antibody (Concizumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized antibody expressed in CHO binding to human TFPI. Concizumab is a monoclonal IgG4 antibody (mAb) that binds to the Kunitz-type protease inhibitor (KPI) 2 domain of TFPI thereby blocking the interaction of this domain with the active site of FXa.

See other products for "TFPI"

Recombinant Antibody

Rabbit Monoclonal Antibody

CAT Product Name Application Type
MOR-3547 Rabbit Anti-TFPI Recombinant Antibody (clone DS3547AB) WB Rabbit IgG

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-734 Afuco™ Anti-TFPI ADCC Recombinant Antibody (Concizumab), ADCC Enhanced ELISA, IP, FC, FuncS, Neut, IF ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-734. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare